Dienogest versus continuous oral levonorgestrel/EE in patients with endometriosis: what's the best choice?
01 Pubblicazione su rivista
Piacenti Ilaria, Viscardi Maria Federica, Masciullo Luisa, Sangiuliano Chiara, Scaramuzzino Sara, Piccioni Maria Grazia, Muzii Ludovico, Benedetti Panici Pierluigi, Porpora Maria Grazia
ISSN: 1473-0766
Combined oral contraceptives (COC) and progestogens are widely used for the treatment of endometriosis. The objective of the study is to compare the efficacy of dienogest 2 mg vs continuous oral levonorgestrel/EE (levonorgestrel 0.1 mg/ethinyl estradiol 0.02 mg) on ovarian endometriomas, deep infiltrating endometriosis (DIE), chronic pelvic pain (CPP), dyspareunia, analgesic use, quality of life (QoL), compliance and side effects.